Cargando…

Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide

Soluble (s)ST2 has been proposed as a useful biomarker for heart failure (HF) patient management. Myocardial damage or mechanical stress stimulate sST2 release. ST2 competes with a membrane bound receptor (ST2 ligand, or ST2L) for interleukin-33 (IL-33) binding, inhibiting the effects induced by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riccardi, Mauro, Myhre, Peder L., Zelniker, Thomas A., Metra, Marco, Januzzi, James L., Inciardi, Riccardo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672197/ https://www.ncbi.nlm.nih.gov/pubmed/37998526 http://dx.doi.org/10.3390/jcdd10110468

Ejemplares similares

Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
por: Wu, Alan H.B.
Publicado: (2012)

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
por: Meijers, Wouter C., et al.
Publicado: (2021)

Natriuretic Peptide Testing in Primary Care
por: Rehman, Shafiq U, et al.
Publicado: (2008)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction
por: Januzzi, James L., et al.
Publicado: (2021)

Inflammation in acute heart failure
por: Garofalo, Manuel, et al.
Publicado: (2023)

Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches
por: Stienen, Susan, et al.
Publicado: (2020)

The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure
por: Zhang, Rongcheng, et al.
Publicado: (2014)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

The Diagnostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide and Soluble ST2 for Heart Failure in Chronic Kidney Disease Patients: A Comparative Analysis
por: Ma, Hongzhen, et al.
Publicado: (2023)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Prognostic significance of serum potassium in patients hospitalized for acute heart failure
por: Lombardi, Carlo Mario, et al.
Publicado: (2022)

Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction
por: Riccardi, Mauro, et al.
Publicado: (2022)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
por: Fu, Shihui, et al.
Publicado: (2018)

Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
por: Cunha, Filipe M., et al.
Publicado: (2017)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
por: Marinescu, Mihai, et al.
Publicado: (2023)

Role of Cardiac Natriuretic Peptides in Heart Structure and Function
por: Sarzani, Riccardo, et al.
Publicado: (2022)

NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and Beyond
por: Inazumi, Hideaki, et al.
Publicado: (2022)

Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment
por: Inciardi, Riccardo M., et al.
Publicado: (2022)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021)

The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure †
por: Testa, Marzia, et al.
Publicado: (2018)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients
por: Feola, Mauro, et al.
Publicado: (2016)

Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis
por: McLellan, Julie, et al.
Publicado: (2020)

Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study
por: Taylor, Clare J, et al.
Publicado: (2022)

Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients
por: Leto, Laura, et al.
Publicado: (2015)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The potential value of integrated natriuretic peptide and echo-guided heart failure management
por: Scali, Maria Chiara, et al.
Publicado: (2014)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v56h2dboqc4ev6gmaeqfo3tnmk